BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)

Clinical trial NCT01924845 · TERMINATED

Trial details

NCT number: NCT01924845
Sponsor: BioMarin Pharmaceutical
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Late-onset Pompe Disease

Start date: 2014-04-01
Primary completion: 2016-09-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.